http://del.icio.us/pennmedicinenews/cancer bookmarks tagged cancer by pennmedicinenews https://shop.icio.us/sales/the-limited-edition-black-hawk-drone-hd-camera?utm_source=del.icio.us&utm_medium=referral&utm_campaign=the-limited-edition-black-hawk-drone-hd-camera https://shop.icio.us/sales/the-limited-edition-black-hawk-drone-hd-camera?utm_source=del.icio.us&utm_medium=referral&utm_campaign=the-limited-edition-black-hawk-drone-hd-camera https://shop.icio.us/sales/the-limited-edition-black-hawk-drone-hd-camera?utm_source=del.icio.us&utm_medium=referral&utm_campaign=the-limited-edition-black-hawk-drone-hd-camera https://shop.icio.us/sales/the-limited-edition-black-hawk-drone-hd-camera?utm_source=del.icio.us&utm_medium=referral&utm_campaign=the-limited-edition-black-hawk-drone-hd-camera pennmedicinenews's links Our #1 Best-Selling Drone--Meet the Dark Night of the Sky! Wed, 29 Feb 2012 21:22:33 +0000 http://del.icio.us/url/713b9bc5da5c1f9d3d7d138ee9e6a76d#pennmedicinenews http://philadelphia.cbslocal.com/2011/12/05/health-mans-best-friend-helping-with-brain-cancer-vaccine-research/ http://del.icio.us/url/713b9bc5da5c1f9d3d7d138ee9e6a76d http://feeds.del.icio.us/v2/rss/url/713b9bc5da5c1f9d3d7d138ee9e6a76d pennmedicinenews's links CBS 3 features a new cancer vaccine helping both dogs and humans with brain tumors. The vaccine is made of cancer cells that stimulate the immune system to fight the tumor, and perhaps even stop it from recurring. Penn Neurosurgery and the Abramson Cancer Center are now enrolling newly diagnosed patients with glioblastoma for vaccine trials. Communications placement cbs3 regional_philadelphia december 2011 fy12 q2 neurosurgery cancer abramson_cancer_center km for-clips communications_placement neuro_psych neuro_neurosurgery imported Mon, 07 Feb 2011 15:58:03 +0000 http://del.icio.us/url/49120898ea1f835c1569e5e43a7a6004#pennmedicinenews http://www.philly.com/philly/health_and_science/20110207_Anna_Meadows__champion_of_cancer_survival__honored_by_Children_s_Hospital.html?page=2&c=y http://del.icio.us/url/49120898ea1f835c1569e5e43a7a6004 http://feeds.del.icio.us/v2/rss/url/49120898ea1f835c1569e5e43a7a6004 pennmedicinenews's links Linda Jacobs, PhD, RN, director of the Abramson Cancer Center's LIVESTRONG Survivorship Center of Excellence, is quoted in a Philadelphia Inquirer profile of Anna Meadows, MD, the recently retired Children's Hospital of Philadelphia childhood cancer survivorship expert. Jacobs called Meadows, a longtime collaborator on Penn's programs for cancer survivors, "an incredible mentor to all of us." philadelphia_inquirer Linda_Jacobs cancer survivorship communications_placement in-the-news 2011 february FY11 Q3 Fri, 04 Feb 2011 16:21:38 +0000 http://del.icio.us/url/3671b6004abba88054aee2f31f1fcd95#pennmedicinenews http://www.newsworks.org/index.php/health-science/item/9909-cancer http://del.icio.us/url/3671b6004abba88054aee2f31f1fcd95 http://feeds.del.icio.us/v2/rss/url/3671b6004abba88054aee2f31f1fcd95 pennmedicinenews's links Overexpression or hyperactivation of ErbB cell-surface receptors drives the growth of many breast cancers. Drugs, like Herceptin, that block the receptors’ signals halt tumor progression in some patients. However, not all patients’ tumors respond, with some becoming resistant over time. Marcelo G. Kazanietz, PhD, professor of Pharmacology and colleagues, report that a protein called P-Rex1 is crucial for signal transmission from ErbB receptors. They found that P-Rex1 is overexpressed in nearly 60 percent of breast cancer samples tested and patients whose tumors express P-Rex1 were more likely to develop metastasis. They identified a downstream target of the ErbB receptors which seems to be crucial for cancer cell proliferation, migration, and metastasis. Kazanietz comments on WHYY Radio about a better understanding of how this pathway works could aid in the development of new targeted drugs. whyy_radio Marcelo_Kazanietz pharmacology cancer breast-cancer womens-health research communications_placement highlights in-the-news 2011 January FY11 Q3 januaryplus Mon, 13 Dec 2010 16:12:58 +0000 http://del.icio.us/url/9651dd82c6b834248b384ce690951736#pennmedicinenews http://abcnews.go.com/Health/OnCallPlusBreastCancerNews/pumping-iron-cancer-weight-training-beneficial-breast-cancer/story?id=12353670 http://del.icio.us/url/9651dd82c6b834248b384ce690951736 http://feeds.del.icio.us/v2/rss/url/9651dd82c6b834248b384ce690951736 pennmedicinenews's links In continuing coverage, new research led by Kathryn Schmitz, PhD, MPH, showing that breast cancer survivors are less likely to develop lymphedema if they lift weights following treatment, was featured in articles on ABCNews.com, Doctor's Guide, and in television stories in more than 20 cities across the U.S. and Canada, including San Franciso, Tampa, Denver and Tucson. "It should be a wakeup call for women to be given a prescription for rehabilitation as a standard of care. If their doctor doesn't automatically make a referral, women need to become squeaky wheels and demand it," Schmitz told ABC News. The research was presented this week at the San Antonio Breast Cancer Symposium and published in JAMA. cancer exercise lymphedema research Kathryn_Schmitz communications_placement breast-cancer womens-health abcnews.com in-the-news 2010 December Fy11 Q2 highlights Wed, 15 Sep 2010 19:47:19 +0000 http://del.icio.us/url/3ab59631b46ec433053dd2217bbd8ce1#pennmedicinenews http://cbs3.com/video/?id=109338@kyw.dayport.com http://del.icio.us/url/3ab59631b46ec433053dd2217bbd8ce1 http://feeds.del.icio.us/v2/rss/url/3ab59631b46ec433053dd2217bbd8ce1 pennmedicinenews's links Bert O'Malley, MD, co-director of the Penn Head and Neck Cancer Center, was interviewed by CBS 3's Talk Philly program about the recent announcement that actor Michael Douglas has throat cancer. Dr. O'Malley discussed the causes, signs and symptoms, and treatment outcomes for head and neck cancer patients, saying "There are different factors involved, but for his type of cancer from what I know, not being his treating doctor, but what I've read, is that his chance of recovery is 60 to 80 percent. Across-the-board head and neck cancer is about 50 percent, and for advanced stages it can be as low as 30 or lower." cbs3 Bert_O'Malley cancer otorhinolaryngology communications_placement in-the-news 2010 September FY11 Q1 Fri, 10 Sep 2010 17:11:30 +0000 http://del.icio.us/url/030ec6912c44bef0bada5f3ef30ad6f0#pennmedicinenews http://cbs3.com/video/?id=109225@kyw.dayport.com http://del.icio.us/url/030ec6912c44bef0bada5f3ef30ad6f0 http://feeds.del.icio.us/v2/rss/url/030ec6912c44bef0bada5f3ef30ad6f0 pennmedicinenews's links Tonight, on all four major television networks, Stand Up to Cancer will be broadcast to the nation in an effort to raise funds and awareness for cancer. CBS Evening News with Katie Couric, local KYW-CBS 3, and many other CBS affiliates in major markets across the country are running previews of segments that will be seen tonight. Craig Thompson, MD, Director of the Abramson Cancer Center is featured in the CBS stories (and will be highlighted during tonight's fundraising simulcast) for his role as a leader of one of the Stand Up to Cancer funded "Dream Teams." Stand Up to Cancer "Dream Teams" have been assembled to develop new treatments to fight specific types of cancer. Thompson and his team are working on finding new treatments for pancreatic cancer, which is one of the deadliest forms of the disease. cbs3 cbs cancer su2c research Craig_Thompson communications_placement in-the-news 2010 September FY11 Q1 Thu, 09 Sep 2010 16:31:38 +0000 http://del.icio.us/url/0e5631af6197933967d3c43afadc02e2#pennmedicinenews http://cbs3.com/video/?id=109110@kyw.dayport.com http://del.icio.us/url/0e5631af6197933967d3c43afadc02e2 http://feeds.del.icio.us/v2/rss/url/0e5631af6197933967d3c43afadc02e2 pennmedicinenews's links CBS3 ran an in-depth story on ovarian cancer to announce that Penn Medicine, the Sandy Roman Ovarian Cancer Foundation, and “Talk Philly” of CBS3, have joined forces to raise awareness and funds for research into the disease that takes the lives of more than half of the women it strikes. George Coukos, MD, PhD, director of the Penn Ovarian Cancer Research Center and the Celso Ramon Garcia Associate Professor of Reproductive Biology, is featured in the story as a “global leader in ovarian cancer research and treatment.” cbs3 george_coukos womens-health gynecologic-cancer research in-the-news 2010 September FY11 Q1 Thu, 26 Aug 2010 17:55:38 +0000 http://del.icio.us/url/23292ca2f25078f89f2dd8de5b2ad894#pennmedicinenews http://www.cbsnews.com/stories/2010/08/26/earlyshow/health/main6807346.shtml http://del.icio.us/url/23292ca2f25078f89f2dd8de5b2ad894 http://feeds.del.icio.us/v2/rss/url/23292ca2f25078f89f2dd8de5b2ad894 pennmedicinenews's links Lynn Schuchter, MD, chief of Hematology and Oncology, is quoted in CBS news stories airing in affiliates across the country commenting on a study published this week in the New England Journal of Medicine. The study, which was conducted by Penn and six other medical centers, is a major advance against the deadliest type of skin cancer, melanoma. The drug tested, PLX4032 genetically targeted and shrank tumors throughout the bodies of 80 percent of patients with terminal melanoma. It is being considered the first drug to successfully exploit the molecular abnormality found in about half of melanoma tumors without harming healthy cells. "This therapy results in dramatic responses for patients -- it's phenomenal. I've been taking care of patients with advanced melanoma for 25 years and this is one of the most important breakthroughs we've seen," said Dr. Schuchter. cbs3 cbs lynn_m._schuchter melanoma cancer research communications_placement in-the-news 2010 August FY11 Q1 Fri, 20 Aug 2010 14:08:40 +0000 http://del.icio.us/url/9b7e2e6f0bf26d1fd5c81428b9ca6be1#pennmedicinenews http://www.medscape.com/viewarticle/727141_print http://del.icio.us/url/9b7e2e6f0bf26d1fd5c81428b9ca6be1 http://feeds.del.icio.us/v2/rss/url/9b7e2e6f0bf26d1fd5c81428b9ca6be1 pennmedicinenews's links Eli Glatstein, MD, vice chairman of the Department of Radiation Oncology was featured in Medscape Oncology in their newly established "Profiles in Oncology" series. Glatstein, who received the Distinguished Achievement Award from the American Society of Clinical Oncology (ASCO) in recognition of his significant impact on the diagnosis and treatment of a number of cancers, particularly Hodgkin's disease, was praised in the profile by his colleague Stephen Hahn, MD, professor and chair of the Department of Radiation Oncology. "Dr. Glatstein is a true role model for all physicians, but particularly oncologists," says Hahn. "He's a humanist. He interacts well with people. He cares about what happens to patients and he cares about their outcome. To be able to deliver a treatment and then try to make people better is what he is all about." Eli_Glatstein stephen_hahn cancer radiation_oncology medscape communications_placement in-the-news 2010 August Q1 FY11 Tue, 13 Jul 2010 16:40:05 +0000 http://del.icio.us/url/40eb261b97f6e920dd4583cc33d460b5#pennmedicinenews http://www.bizjournals.com/philadelphia/blogs/health_care/2010/06/penns_domchek_picked_for_cancer_research_team.html?ana=from_rss&utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+philadelphia_blog_healthcare+%28Philadelphia+Health+Care%29 http://del.icio.us/url/40eb261b97f6e920dd4583cc33d460b5 http://feeds.del.icio.us/v2/rss/url/40eb261b97f6e920dd4583cc33d460b5 pennmedicinenews's links The Philadelphia Business Journal reported on the appointment of Susan M. Domchek, MD, associate professor of Medicine and the director of the Cancer Risk Evaluation Program at Penn’s Abramson Cancer Center, to the Susan G. Komen for the Cure’s new scientific advisory council. Komen for the Cure is the world’s largest breast cancer organization. A clinical researcher, Domchek was picked to serve on a new panel of more than 60 top-ranking scientists, clinicians, and advocates recruited to guide the organization’s research program. philadelphia_business_journal Susan_Domchek cancer in-the-news 2010 June FY10 Q4